期刊文献+

Apocynin降低1型糖尿病小鼠心肌组织炎症因子的表达 被引量:8

Apocynin decreases cardiac cytokines in STZ-induced diabetic cardiomyopathy
下载PDF
导出
摘要 目的:探讨NADPH氧化酶抑制剂apocynin对1型糖尿病小鼠心肌组织IL-1β、IL-18、TNF-α和COX-2表达的影响及其机制研究。方法:C57小鼠腹腔注射STZ建立1型糖尿病动物模型,44只8周龄雄性小鼠分为对照组(sham,n=6)、apocynin对照组(Apo,n=6)、1型糖尿病组(STZ,n=16)及1型糖尿病apocynin治疗组(STZ+Apo,n=16)。实验于8周末结束,运用超声心动图检测小鼠心脏功能,以实时定量RT-PCR技术测定心肌组织IL-1β、IL-18、TNF-α和COX-2mRNA表达,以Western blotting检测心肌组织磷酸化Akt表达。结果:1型糖尿病小鼠心脏功能降低伴随心肌组织IL-1β、IL-18、TNF-α和COX-2 mRNA表达增加,STZ+Apo组小鼠心脏功能增高伴随心肌组织IL-1β、IL-18、TNF-α和COX-2 mRNA表达减少;1型糖尿病小鼠心肌组织磷酸化Akt显著减少,STZ+Apo组心肌组织磷酸化Akt明显增加。结论:Apocynin提高1型糖尿病小鼠心脏功能伴随显著减少心肌组织IL-1β、IL-18、TNF-α和COX-2mRNA的表达,其机制可能与增加心肌组织磷酸化Akt表达密切相关。 AIM : This study was to investigate the effects of apocynin on the expression of IL -1β, IL - 18, TNF -α and COX - 2 mRNA in the diabetic cardiomyopathy heart. METHODS : Diabetes was induced in 8 - week old C57 mice with one intraperitoneal injection of streptozotocin (STZ, 100 mg/kg). The experiments were divided into 4 groups : sham ( n = 6 ) , apocynin control ( Apo, n = 6 ) , diabetic cardiomyopathy ( STZ, n = 16 ) and apocynin treatment (STZ + Apo, n = 16). At the end of 8 weeks after induction of diabetes, cardiac functions were evaluated by echocardiography. Cardiac tissue was analyzed for the expression of IL -1β, IL - 18, TNF -α, COX - 2 mRNA and phosphorylated Akt by real - time RT - PCR and Western blotting, respectively. RESULTS : The expression of IL -1β, IL - 18, TNF -α and COX- 2 mRNA increased in diabetic cardiomyopathy heart accompanied with cardiac dysfunction. Cardiac functions were improved with decreased levels of IL -1β, IL - 18, TNF -α and COX - 2 mRNA expression in apocynin - treated heart. Compared with reduction of phosphorylated Akt, apocynin significantly increased phosphorylation of Akt in diabetic cardiomyopathy heart. CONCLUSION: Apocynin decreases cardiac IL -1β, IL - 18, TNF -α and COX -2 mRNA expression accompanied with improved cardiac function, which associates with the increase of phosphorylated Akt in diabetic cardiomyopathy heart.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2009年第11期2109-2112,共4页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.30772021) 教育部新世纪优秀人才计划资助项目(No.NCEF-06-0354) 上海市浦江人才计划资助项目(No.09PJ148400)
关键词 APOCYNIN 糖尿病心肌病 细胞因子 Apocynin Diabetic cardiomyopathy Cytokines
  • 相关文献

参考文献11

  • 1Westermann D, Rutschow S, van Linthout S, et al. Inhibition of p38 mitogen - activated protein kinase attenuates left ventricular dysfunction by mediating pro - inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus [ J ]. Diabetologia, 2006, 49 (10) :2507 - 2513.
  • 2Aneja A, Tang WH, Bansilal S, et al. Diabetic cardiomyopathy : insights into pathogenesis, diagnostic challenges, and therapeutic options[J]. Am J Med, 2008, 121 (9) : 748 - 757.
  • 3Ye G, Metreveli NS, Ren J, et al. Metallothionein prevents diabetes - induced deficits in cardiomyocytes by in- hibiting reactive oxygen species production [ J ]. Diabetes, 2003, 52(3) :777 -783.
  • 4Qin F, Simeone M, Patel R. Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction[J]. Free Radic Biol Med, 2007, 43(2) : 271 -281.
  • 5Westermann D, van Linthout S, Dhayat S, et al. Cardioprotective and anti - inflammatory effects of interleukin converting enzyme inhibition in experimental diabetic cardiomyopathy [ J ]. Diabetes, 2007, 56 ( 7 ) : 1834 - 1841.
  • 6Tschope C, Walther T, Escher F, et al. Transgenic activation of the kallikrein - kinin system inhibits intramyocardial inflammation, endothelial dysfunction, and oxidative stress in experimental diabetic cardiomyopathy[ J]. FASEB J, 2005, 19(14) :2057 -2059.
  • 7Matharu NM, McGettrick HM, Salmon M, et al. Inflammatory responses of endothelial cells experiencing reduction in flow after conditioning by shear stress [ J ]. J Cell Physiol, 2008, 216 (3) :732 - 741.
  • 8Peng T, Lu X, Feng Q. Pivotal role of gp91phox - contai- ning NADH oxidase in lipopolysaccharide - induced tumor necrosis factor - alpha expression and myocardial depression [ J ]. Circulation, 2005,111 ( 13 ) : 1637 - 1644.
  • 9郭晓纲,陈君柱,朱建华,张芙荣,邱原刚,尚云鹏.咪达普利拉对人心脏成纤维细胞基质金属蛋白酶-2和抑制剂-2的作用及机制研究[J].中国病理生理杂志,2008,24(7):1263-1269. 被引量:1
  • 10Shen E, Fan J, Chen R, et al. Phospholipase C gamma 1 signalling regulates lipopolysaccharide - induced cyclooxygenase- 2 expression in cardiomyocytes [ J ]. J Mol Cell Cardiol, 2007, 43 (3) : 308 - 318.

二级参考文献20

  • 1陈齐红,覃数,汪华玲,肖骅.血管紧张素Ⅱ刺激心衰患者外周血单个核细胞分泌TNF-α和NO[J].中国病理生理杂志,2005,21(6):1097-1100. 被引量:12
  • 2程超,郭爱林,吴伟康,罗红鹤,钟佛添,张萌.PRL-2基因转染对肝细胞基质金属蛋白酶及其抑制剂表达的影响[J].中国病理生理杂志,2006,22(11):2189-2193. 被引量:3
  • 3Galls ZS, Muszynski M, Sukhova GK, et al. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions [J]. Ann New York Acad Sci, 1995,748 ( 1 ) : 501 - 507.
  • 4Spinale FG. Matrix metalloproteinases: regulation and dysregulation in the failing heart [ J ]. Circ Res, 2002,90 (5) : 520 -530.
  • 5Benjamin IJ. Matrix metalloproteinases: from biology to therapeutic strategies in cardiovascular disease [ J]. J Invest Mcd, 2001, 49(5) : 381 -397.
  • 6Hayashidani S,Tsutsui H, Ikeuchi M, et al. Targeted deletion of MMP - 2 attenuates early LV rupture and late remodeling after experimental myocardial infarction [ J]. Am J Physiol Heart Circ Physiol, 2003,285 ( 3 ) : H1229 - H1235.
  • 7Matsusaka H,Ide T,Matsushima S, et al. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload [ J ]. Hypertension ,2006,47 (4) : 711 - 717.
  • 8Xie Z, Singh M, Singh K. Differential regulation of matrix metalloproteinase -2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin - lbeta [J]. J Biol Chem,2004,279(38) : 39513 -39519.
  • 9Adamopoulos S, Parissis JT, Kremastinos DT. A glossary of circulating eytokines in chronic heart failure [ J]. Eur J Heart Fail, 2001,3(5) : 517 -526.
  • 10Aukrust P, Ueland T, Lien E, et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy [ J ]. Am J Cardiol, 1999,83 ( 3 ) : 376 -382.

同被引文献115

引证文献8

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部